NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN A PHASE II STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

被引：0

作者：

Nayak, Lakshmi ^{[1
]}

Molinaro, Annette ^{[2
]}

Peters, Katherine ^{[3
]}

Clarke, Jennifer ^{[2
]}

Jordan, Justin ^{[4
]}

de Groot, John ^{[5
]}

Nghiemphu, Phioanh ^{[6
]}

Kaley, Thomas ^{[7
]}

Colman, Howard ^{[8
]}

McCluskey, Christine ^{[1
]}

Gaffey, Sarah ^{[1
]}

Smith, Timothy ^{[9
]}

Cote, David ^{[10
]}

Severgnini, Mariano ^{[1
]}

Yearley, Jennifer ^{[11
]}

Zhao, Qing ^{[11
]}

Blumenschein, Wendy ^{[11
]}

Duda, Gabriel ^{[4
]}

Muzikansky, Alona ^{[4
]}

Jain, Rakesh ^{[12
]}

Wen, Patrick ^{[1
]}

Reardon, David ^{[13
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA

[3] Duke Univ, Med Ctr, Durham, NC USA

[4] Massachusetts Gen Hosp, Boston, MA 02114 USA

[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[6] Univ Calif Los Angeles, Los Angeles, CA USA

[7] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[8] Huntsman Canc Inst, Salt Lake City, UT USA

[9] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA

[10] BWH, Boston, MA USA

[11] Merck, Kenilworth, NJ USA

[12] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Labs, Boston, MA 02115 USA

[13] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA

来源：

NEURO-ONCOLOGY | 2020年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NCOG-44

引用

页码：138 / 139

页数：3

共 50 条

[21] PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA
Cloughesy, Tim
Finocchiaro, Gaetano
Belda-Iniesta, Cristobel
Recht, Lawrence
Brandes, Alba A.
Pineda, Estela
Mikkelsen, Tom
Chinot, Olivier
Balana, Carmen
Macdonald, David
Westphal, Manfred
Hopkins, Kirsten
Weller, Michael
Bruey, Jean-Marie
Liu, Bo
Verret, Wendy
NEURO-ONCOLOGY, 2014, 16
[22] Phase II study of pembrolizumab plus SurVaxM for glioblastoma at first recurrence.
Ahluwalia, Manmeet Singh
Peereboom, David M.
Ciolfi, Marci
Schilero, Cathy
Hobbs, Brian
Ciesielski, Michael J.
Fenstermaker, Robert Alan
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[23] B VALIDATING THE NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY SCALE FOR VIRTUAL VISITS: A PILOT STUDY
Roberto, K.
Granovskaya, I
Chan, A.
Theriault, A.
Mitchell, S.
Perry, J.
Nayak, L.
Lim-Fat, M.
NEURO-ONCOLOGY, 2024, 26
[24] A phase II study of pembrolizumab in patients with recurrent thymic carcinoma.
Giaccone, Giuseppe
Thompson, Jillian
Crawford, Jenny
McGuire, Colleen
Manning, Maria
Subramaniam, Deepa Suresh
Liu, Stephen V.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[25] REAL WORLD INTEGRATION OF THE NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN CLINICAL PRACTICE IN PATIENTS WITH IDH-WT GBM
Lim-Fat, Mary Jane
Allen, Marie
Smith, Timothy
Youssef, Gilbert
Andersen, Brian
Akintola, Oluwatosin
Berger, Tamar
Budhu, Joshua
Hsieh, Annie
Aquilanti, Elisa
Batchelor, Tracy
Beroukhim, Rameen
Chukwueke, Ugonma
Castro, L. Nicolas Gonzalez
Lee, Eudocia Quant
McFaline-Figueroa, J. Ricardo
Doherty, Lisa
Stefanik, Jennifer
Taubert, Christina
Torres, Alexandra
Wen, Patrick
Reardon, David
Nayak, Lakshmi
NEURO-ONCOLOGY, 2021, 23 : 114 - 114
[26] Second line BCNU plus CPT-11 chemotherapy in recurrent glioblastoma (GBM): Phase II study of GICNO (Italian Neuro-Oncology Group).
Brandes, AA
Tosoni, A
Reni, M
Valduga, F
Basso, U
Lonardi, S
Pasetto, LM
Blatt, V
Monfardini, S
Ermani, M
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 111S - 111S
[27] Phase Ib study of olinvacimab (O) with pembrolizumab (P) in patients with recurrent glioblastoma (rGBM).
Nowak, Anna K.
Cher, Lawrence
Bowyer, Samantha
Gan, Hui Kong
Long, Anne Poh
Balasubramanian, Adithya
Lee, Seon Young
Lee, Weon Sup
Yoo, Jin-San
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[28] PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP
Aoki, Tomokazu
Arakawa, Yoshiki
Ueba, Tetsuya
Oda, Masashi
Nishida, Namiko
Akiyama, Yukinori
Tsukahara, Tetsuya
Mikuni, Nobuhiro
Miyamoto, Susumu
NEURO-ONCOLOGY, 2017, 19 : 6 - 6
[29] PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP
Aoki, Tomokazu
Arakawa, Yoshiki
Ueba, Tetsuya
Oda, Masashi
Nishida, Namiko
Akiyama, Yukinori
Tukahara, Tetsuya
Iwasaki, Koichi
Mikuni, Nobuhiro
Miyamoto, Susumu
NEURO-ONCOLOGY, 2018, 20 : 25 - 25
[30] PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP
Aoki, T.
Arakawa
Ueba
Oda
Nishida
Akiyama
Tsukahara
Iwasaki
Mikuni
Miyamoto
NEURO-ONCOLOGY, 2017, 19 : 70 - 70

← 1 2 3 4 5 →